Program

84
22
4
3
1
1

Journal Year Published

3
17
12
19
13
8
7
8
2
1

Author

90
183
175
135
134
127
119
118
115
108
87
81
74
57
52
50
44
43
42
34

Category

57
31
27
7
4
2
1
1
1

Keyword

37
20
15
12
12
10
10
8
7
7
7
7
6
6
5
5
5
5
5
5

Journal

8
7
6
6
5
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1

NCATS Publications

Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy.


Feliz-Mosquea YR, Christensen AA, Wilson AS, Westwood B, Varagic J, Meléndez GC, Schwartz AL, Chen QR, Mathews Griner L, Guha R, Thomas C, Ferrer-Alegre M, Merino MJ, Cook KL, Roberts DD, Soto-Pantoja DR


Breast Cancer Res. Treat. , (172), 69-82, 2018.

Article Pubmed

MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma.


Yohe ME, Gryder BE, Shern JF, Song YK, Chou HC, Sindiri S, Mendoza A, Patidar R, Zhang X, Guha R, Butcher D, Isanogle KA, Robinson CM, Luo X, Chen JQ, Walton A, Awasthi P, Edmondson EF, Difilippantonio S, Wei JS, Zhao K, Ferrer-Alegre M, Thomas C, Khan J


Sci Transl Med , (10), 2018.

Article Pubmed

Sample image from publication page

Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells.


Ferrer-Alegre M, Gosline SJC, Stathis M, Zhang X, Guo X, Guha R, Ryman DA, Wallace MR, Kasch-Semenza L, Hao H, Ingersoll R, Mohr D, Thomas C, Verma S, Guinney J, Blakeley JO


Sci Data , (5), 180106, 2018.

Article Pubmed

Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis.


Frankowski KJ, et al.


Sci Transl Med , (10), 2018.

Article Pubmed

Sample image from publication page

A modified gene trap approach for improved high-throughput cancer drug discovery.


Morris SM, Mhyre AJ, Carmack SS, Myers CH, Burns C, Ye W, Ferrer-Alegre M, Olson JM, Klinghoffer RA


Oncogene , 2018.

Article Pubmed

Sample image from publication page

Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma.


McKinnon T, Venier R, Yohe M, Sindiri S, Gryder BE, Shern JF, Kabaroff L, Dickson B, Schleicher K, Chouinard-Pelletier G, Menezes S, Gupta A, Zhang X, Guha R, Ferrer-Alegre M, Thomas C, Wei Y, Davani D, Guidos CJ, Khan J, Gladdy RA


Oncogene , 2018.

Article Pubmed

Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein.


Al-Ramahi I, Panapakkam Giridharan SS, Chen YC, Patnaik S, Safren N, Hasegawa J, de Haro M, Wagner Gee AK, Titus SA, Jeong H, Clarke J, Krainc D, Zheng W, Irvine RF, Barmada S, Ferrer-Alegre M, Southall N, Weisman LS, Botas J, Marugan JJ


Elife , (6), 2017.

Article Pubmed

Sample image from publication page